Gene: TMEM141
Official Full Name: transmembrane protein 141provided by HGNC
Gene Summary: Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24345 | TMEM141 Knockout cell line (HeLa) | Human | TMEM141 | 1:3~1:6 | Negative | Online Inquiry |
KO24346 | TMEM141 Knockout cell line (HCT 116) | Human | TMEM141 | 1:2~1:4 | Negative | Online Inquiry |
KO24347 | TMEM141 Knockout cell line (HEK293) | Human | TMEM141 | 1:3~1:6 | Negative | Online Inquiry |
KO24348 | TMEM141 Knockout cell line (A549) | Human | TMEM141 | 1:3~1:4 | Negative | Online Inquiry |
TMEM141 Gene Knockout Cell Lines are specialized cellular models developed to study the role of the TMEM141 gene in various biological processes. These cell lines are generated through targeted gene editing techniques, allowing for the precise disruption of TMEM141 expression. This gene is implicated in several critical intracellular pathways, including those related to immune responses, cell signaling, and autophagy, making its knockout an invaluable tool for researchers looking to dissect the complexities of cellular functions.
The primary function of the TMEM141 gene knockout is to elucidate the mechanisms through which TMEM141 influences cellular behavior. By inhibiting its expression, researchers can investigate downstream effects on protein trafficking, membrane dynamics, and cellular stress responses, offering insights into its role in health and disease. The resulting cellular phenotypes serve as a platform for functional assays, providing the ability to explore therapeutic targets for various diseases, including cancer and autoimmune disorders.
These cell lines possess significant scientific importance, particularly in research settings focused on gene function and cellular mechanisms. They can be employed in high-throughput screenings, drug efficacy tests, and genetic studies aimed at understanding the implications of TMEM141 dysregulation in disease models. Moreover, in clinical research, this knockout model can help identify new biomarkers and potential targets for therapeutic intervention.
What sets TMEM141 Gene Knockout Cell Lines apart from alternative models is their specificity and reliability. Unlike general knockout strategies, our cell lines ensure targeted gene disruption with high transfection efficiency and minimal off-target effects. This specificity enhances the reproducibility of experimental results, ultimately resulting in more robust data.
For researchers and clinicians seeking to advance their understanding of gene function and disease mechanisms, these cell lines represent an invaluable resource. With our expertise in generating high-quality biological products, we are committed to providing the tools necessary for pioneering research and impactful clinical applications that drive innovation in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.